Seeking Alpha

THLD
Threshold Pharmaceuticals, Inc.

5/26/2012, 3:16 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
THLD Market Currents more »
  • Friday 3:24 PM Cowen says when you consider the potential of Threshold Pharmaceuticals (THLD -0.2%) pancreatic cancer drug TH-302, the stock is definitely undervalued. The firm estimates the sales potential for the drug in the U.S. alone is close to $1.5B.
    Comment!
    [Healthcare, Quick Ideas]
THLD in Focus more »
THLD Latest Transcript more »
Currently, there are no transcripts for THLD.
THLD Instablog posts more »
  • Threshold TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer
    Fri, May 11 • EXPstocktrader • Comment!
  • Threshold Pharmaceuticals, Inc. (THLD) Names Dr. Tillman Pearce As Chief Medical Officer
    Fri, Feb 17 • MissionIR • Comment!
  • Threshold Pharmaceuticals, Inc. (THLD) Names Dr. Tillman Pearce As Chief Medical Officer
    Fri, Feb 17 • QualityStocks • Comment!
  • Threshold Pharmaceuticals, Inc. (THLD) Reports Promising Results in Phase 1 Trial for Leukemia
    Wed, Dec 14, 2011 • QualityStocks • Comment!
  • Threshold Pharmaceuticals (THLD) Data demonstrates Candidate Potential
    Fri, Oct 28, 2011 • MissionIR • Comment!
Write a post on THLD
THLD StockTalks
THLD vs. ETF Alternatives
Company Description
Currently, there's no company description for THLD.
Sector: Healthcare
Industry: Biotechnology
Country: United States